Risk of Thromboembolism in Patients with Immune Thrombocytopenia

Shojiro Takagi^*, Iwao Suzuki and Saiko Watanabe

Development and Medical Affairs Division, GlaxoSmithKline K.K, GSK Building, 4-6-15, Sendagaya, Shibuya-ku, Tokyo, 151-8566, Japan

^*Corresponding Author: Shojiro Takagi, GSK Building, 4-6-15, Sendagaya, Shibuya-ku, Tokyo, 151-8566, Japan, Tel: +81-3-5786-6294, Fax: +81-3-5786-5235 Email: